This retrospective cohort study examines SHBG variation and hormonal clustering in men with sexual dysfunction, indicating potential impacts on diagnosis and treatment.
Introduction Hypogonadism diagnosis requires both clinical symptoms and at least 2 low total testosterone (TT; ng/dL). However, testosterone bioavailability also depends on sex hormone binding globulin (SHBG; nmol/L), influenced by age, BMI, and comorbidities. This study evaluated SHBG variation between men with different hormonal profiles and between serial measurements in the same patient. Methods A retrospective cohort of 96 men from a tertiary center with sexual dysfunction requiring surgical treatment. Inclusion required two complete hormonal panels: TT, calculated free testosterone (cFT; pmol/mL), SHBG, luteinizing hormone (LH; IU/L), FSH, estradiol. cFT was calculated using TT and SHBG. SHBG was compared across hormonal clusters (A–E) and between first and second measurements in each patient. SHBG values of 80 patients in a control group of vasectomized men without sexual symptoms was also analyzed. Results Patients with sexual dysfunction (median age 67.5) showed wide SHBG values (6–110.5 nmol/L). Controls (median age 39) also showed high variability (9.5–108.8). SHBG varied up to 20-fold across individuals. Intraindividual stability was moderate: 72.6% remained in the same SHBG tercile between tests, but 40.6% changed hormonal clusters. Conclusion SHBG shows wide inter- and intraindividual variability, potentially altering hormonal classification and impacting hypogonadism diagnosis and treatment decisions. Financing No conflict.
No takes yet. Share an insight, caveat, or question.
Horta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: